ライフサイエンスコーパス: rheumatica

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ions, and malignancies can mimic polymyalgia rheumatica.

2 e phase reactants are typical of polymyalgia rheumatica.

3 everal other disorders can mimic polymyalgia rheumatica.

4 heralded by symptoms of isolated polymyalgia rheumatica (1 case versus 5 in the placebo group; P = 0.

5 million for 1995), 711,000 have polymyalgia rheumatica, 228,000 have giant cell arteritis, up to 3.0

6 nical features characteristic of polymyalgia rheumatica and/or giant cell arteritis (GCA).

7 are headache, jaw claudication, polymyalgia rheumatica, and visual symptoms.

8 provides a clinical overview of polymyalgia rheumatica, focusing on risk factors, diagnosis, treatme

9 Polymyalgia rheumatica is a chronic, inflammatory disorder of unknow

10 Polymyalgia rheumatica is an inflammatory disease that affects the s

11 1-1.2), P=9.8 x 10(-11)) and for polymyalgia rheumatica near C6orf10 at rs6910071 (OR=1.5 (95% CI: 1.

12 Polymyalgia rheumatica occurred with similar frequency in both patie

13 Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are rela

14 Polymyalgia rheumatica (PMR) has an abrupt onset of inflammatory sym

15 or joint disease localization in polymyalgia rheumatica (PMR) is poorly understood.

16 To evaluate the impact of polymyalgia rheumatica (PMR) on clinical outcomes and quality of lif

17 Imaging studies in GCA and polymyalgia rheumatica (PMR) suggest that vasculitis can affect mult

18 In patients with polymyalgia rheumatica (PMR), a subclinical variant of GCA, adventit

19 bnormalities, fever, concomitant polymyalgia rheumatica (PMR), and histologic evidence of giant cell

20 are headache, jaw claudication, polymyalgia rheumatica (PMR), and visual symptoms, but 40% of patien

21 thematosus, psoriatic arthritis, polymyalgia rheumatica (PMR), giant cell arteritis, ankylosing spond

22 scular diseases in patients with polymyalgia rheumatica (PMR).

23 logy classification criteria for polymyalgia rheumatica (PMR).

24 -interleukin 6, in patients with polymyalgia rheumatica that is refractory to glucocorticoids require

25 One patient with polymyalgia rheumatica who developed the inhibitor while receiving p

26 osing vasculitis; and "isolated" polymyalgia rheumatica with myalgias, systemic inflammation, and sub

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。